Peptide Half-Life Tracking

1. What Half-Life Means When Tracking

Half-life is the time it takes for a modeled amount of a compound to fall by 50%. If a peptide has a 24-hour half-life in your tracking reference, the model estimates that one half of the logged amount remains after 24 hours, one quarter remains after 48 hours, one eighth remains after 72 hours, and so on.

That does not mean the compound suddenly turns off at one exact time. Half-life describes a curve, not a switch. A tracker uses that curve to estimate relative amount over time, show overlap between doses, and make timing patterns easier to see.

Useful terms: half-life means time to 50% remaining; decay means the modeled decline after a dose; accumulation means overlap from repeated doses; steady state means a repeating peak-and-trough pattern under a consistent schedule.

2. The Half-Life Formula

The common first-order half-life model uses exponential decay. The remaining amount at a future time is based on the starting amount, elapsed time, and half-life.

The equivalent exponential form is C(t) = C₀e^-kt, where k = ln(2) / t_1/2. The two forms describe the same model; the half-life version is usually easier to read for tracking.

For tracking, the units just need to be consistent. If the dose is in mg, the remaining modeled amount is in mg. If elapsed time is measured in hours, half-life should also be in hours. If elapsed time is measured in days, half-life should also be in days.

After one half-life, 50% remains. After two half-lives, 25% remains. After three half-lives, 12.5% remains. After five half-lives, about 3.1% remains. The model keeps declining; it does not become literal zero at a fixed time.

3. Real-World Example: Semaglutide Half-Life

Suppose a logged 1 mg dose of Semaglutide. Semaglutide has an elimination half-life of approximately 165 hours (about 1 week or 7 days)^[1]. This long half-life is what makes once-weekly dosing effective for sustained weight loss.^[2]

Because the half-life (165 hours) is roughly the same as the typical dosing interval (once weekly / 168 hours), significant accumulation occurs. When taking a second weekly dose, about 50% of the first dose is still modeled to be in the system. The model indicates steady-state exposure is achieved after 4 to 5 weeks.

A half-life model is most useful as a consistency and education tool. It can help you compare what was logged, when it was logged, and how a reference decay curve changes between logs. It should not be used to decide dose changes without qualified medical guidance.

4. Accumulation and Overlap

When multiple doses are logged, a tracker calculates each dose as its own decay curve, then adds the remaining modeled amounts together at each point in time. This is why the total modeled amount can rise after a new log while still carrying a remainder from earlier logs.

Each logged dose contributes less over time, and the total is the combined remainder from all previous entries. This is a bookkeeping model, not a lab measurement.

With a repeated schedule, the curve may eventually settle into a pattern where each new peak and next trough are similar to the previous cycle. In simplified first-order models, this is often described as steady state. Many educational references use about four to five half-lives as a rough time frame for approaching steady state, but real-world interpretation depends on the compound, person, formulation, and clinical context.

Tracking boundary: a modeled curve is not a blood test, diagnosis, safety signal, or personalized pharmacokinetic analysis. It is a visual estimate based on logged amounts and reference half-life values.

5. Why Half-Life Tracking Helps

Half-life tracking can make a log more readable because it turns separate dose entries into a continuous timeline. Instead of only seeing a list of dates and amounts, you can see how close logs were to each other, whether gaps were longer than usual, and how a schedule creates peaks and troughs.

• Compare logged timing against a planned daily, weekly, or interval schedule.
• See estimated overlap when doses are close together.
• Understand why long half-life references create smoother curves.
• Prepare clearer records for conversations with a clinician or pharmacist.

The model is only as good as the inputs. Incorrect dose amount, unit, time, compound selection, or half-life reference can create misleading output. Keep the log accurate, and treat the output as educational context.

6. Common Mistakes

• Mixing hours and days in the same formula.
• Assuming a half-life estimate can predict exact blood concentration.
• Using a half-life estimate from one compound, salt form, or formulation for another.
• Treating "five half-lives" as a hard medical clearance rule.
• Changing dose timing based only on modeled output instead of qualified guidance.

7. How Peptide Tracker Uses This Concept

Peptide Tracker is built for private logging and visualization. The app can store dose history, schedule reminders, track inventory, and display half-life curves for supported compounds and custom entries. The goal is to help you maintain a clearer record, not to prescribe or recommend treatment decisions.

Use the half-life visualizer as a reference layer next to your log. For clinical interpretation, adverse effects, dose changes, missed doses, or questions about what a curve means for your care, talk with a qualified healthcare professional.